Similar articles for PMID: 31540982

Year	Number of Results
1948	1
1981	1
1988	1
1989	1
1993	1
1999	3
2001	2
2003	2
2005	2
2006	1
2007	2
2008	2
2009	4
2010	4
2011	5
2012	4
2013	7
2014	5
2015	12
2016	16
2017	22
2018	31
2019	31
2020	45
2021	40
2022	34
2023	7
2024	0

1

Loci Encoding Compounds Potentially Active against Drug-Resistant Pathogens amidst a Decreasing Pool of Novel Antibiotics.

Basalla J, Chatterjee P, Burgess E, Khan M, Verbrugge E, Wiegmann DD, LiPuma JJ, Wildschutte H. Basalla J, et al. Appl Environ Microbiol. 2019 Nov 14;85(23):e01438-19. doi: 10.1128/AEM.01438-19. Print 2019 Dec 1. Appl Environ Microbiol. 2019. PMID: 31540982 Free PMC article.

2

Environmental Pseudomonads Inhibit Cystic Fibrosis Patient-Derived Pseudomonas aeruginosa.

Chatterjee P, Davis E, Yu F, James S, Wildschutte JH, Wiegmann DD, Sherman DH, McKay RM, LiPuma JJ, Wildschutte H. Chatterjee P, et al. Appl Environ Microbiol. 2016 Dec 30;83(2):e02701-16. doi: 10.1128/AEM.02701-16. Print 2017 Jan 15. Appl Environ Microbiol. 2016. PMID: 27881418 Free PMC article.

3

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.

Zhanel GG, Golden AR, Zelenitsky S, Wiebe K, Lawrence CK, Adam HJ, Idowu T, Domalaon R, Schweizer F, Zhanel MA, Lagacé-Wiens PRS, Walkty AJ, Noreddin A, Lynch Iii JP, Karlowsky JA. Zhanel GG, et al. Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.

4

The Inhibition Effect of Lactobacilli Against Growth and Biofilm Formation of Pseudomonas aeruginosa.

Shokri D, Khorasgani MR, Mohkam M, Fatemi SM, Ghasemi Y, Taheri-Kafrani A. Shokri D, et al. Probiotics Antimicrob Proteins. 2018 Mar;10(1):34-42. doi: 10.1007/s12602-017-9267-9. Probiotics Antimicrob Proteins. 2018. PMID: 28293865

5

In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis.

Gramegna A, Millar BC, Blasi F, Elborn JS, Downey DG, Moore JE. Gramegna A, et al. J Glob Antimicrob Resist. 2018 Sep;14:224-227. doi: 10.1016/j.jgar.2018.03.002. Epub 2018 Mar 17. J Glob Antimicrob Resist. 2018. PMID: 29559421

6

In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.

Nicholson A, Perry JD, James AL, Stanforth SP, Carnell S, Wilkinson K, Anjam Khan CM, De Soyza A, Gould FK. Nicholson A, et al. Int J Antimicrob Agents. 2012 Jan;39(1):27-32. doi: 10.1016/j.ijantimicag.2011.08.015. Epub 2011 Oct 10. Int J Antimicrob Agents. 2012. PMID: 21993484

7

Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.

Conway SP, Brownlee KG, Denton M, Peckham DG. Conway SP, et al. Am J Respir Med. 2003;2(4):321-32. doi: 10.1007/BF03256660. Am J Respir Med. 2003. PMID: 14719998 Review.

8

Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa.

Pages-Monteiro L, Marti R, Commun C, Alliot N, Bardel C, Meugnier H, Perouse-de-Montclos M, Reix P, Durieu I, Durupt S, Vandenesch F, Freney J, Cournoyer B, Doleans-Jordheim A. Pages-Monteiro L, et al. PLoS One. 2017 Mar 10;12(3):e0173022. doi: 10.1371/journal.pone.0173022. eCollection 2017. PLoS One. 2017. PMID: 28282386 Free PMC article.

9

Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains.

Warawa JM, Duan X, Anderson CD, Sotsky JB, Cramer DE, Pfeffer TL, Guo H, Adcock S, Lepak AJ, Andes DR, Slone SA, Stromberg AJ, Gabbard JD, Severson WE, Lawrenz MB. Warawa JM, et al. Microbiol Spectr. 2022 Oct 26;10(5):e0269322. doi: 10.1128/spectrum.02693-22. Epub 2022 Sep 12. Microbiol Spectr. 2022. PMID: 36094219 Free PMC article.

10

Terminalia bellirica fruit extracts: in-vitro antibacterial activity against selected multidrug-resistant bacteria, radical scavenging activity and cytotoxicity study on BHK-21 cells.

Dharmaratne MPJ, Manoraj A, Thevanesam V, Ekanayake A, Kumar NS, Liyanapathirana V, Abeyratne E, Bandara BMR. Dharmaratne MPJ, et al. BMC Complement Altern Med. 2018 Dec 7;18(1):325. doi: 10.1186/s12906-018-2382-7. BMC Complement Altern Med. 2018. PMID: 30526562 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

265 results

Results by year